Based on Audit Committee recommendations, the Board approved the un-audited financial results for the quarter ended June 30, 2026.
Revenue from operations: ₹607.88 lakh (compared to ₹197.65 lakh in previous quarter)
Other income: ₹13.85 lakh
Total revenue: ₹621.74 lakh
Total expenses: ₹606.30 lakh
Profit before tax: ₹15.44 lakh (compared to loss of ₹35.62 lakh in previous quarter)
Tax expense: Not applicable (shown as negative ₹93.95 in previous quarter)
Net profit for the period: ₹15.44 lakh (compared to ₹58.34 lakh in previous quarter)
Total comprehensive income: ₹15.53 lakh
Basic and diluted earnings per share: ₹0.52
The results were reviewed by the Audit Committee and approved by the Board on August 13, 2026.
Statutory Auditors carried out limited review for the quarter.
2. Appointment of Statutory Auditors
Based on Audit Committee recommendations, the Board recommended appointment of M/s GD S M and Co, Chartered Accountants (FRN: 034194N) as Statutory Auditors.
Term: 5 years commencing from conclusion of AGM in FY 2026-27 until conclusion of AGM in 2031.
Subject to shareholder approval at forthcoming AGM.
The firm offers full range of services including audit under Companies Act, Income Tax, GST Audit, Internal Audit, and consultancy in taxation matters.
3. 41st Annual General Meeting
Board approved convening of 41st AGM through Video Conferencing/Other Audio-Visual Means on Tuesday, September 29, 2026.
Draft notice to be issued and dispatched to shareholders for approval on matters cited in the AGM notice.
4. Board Report for FY26
Board considered and approved the Board's Report for the financial year ended March 31, 2026.
Additional Information
The company is engaged primarily in the pharmaceutical business with no separate reportable segments as per Ind-AS 108.
The financial results are available on company's website (www.brawnbiotech.com) and BSE website (www.bseindia.com).
The disclosure includes limited review report from Rajiv Udai & Associates, Chartered Accountants (Firm Registration No. 018764N) dated August 13, 2026.
CFO certification under Regulation 33(2)(a) of SEBI (LODR) Regulations, 2015 was provided by Rati Garg, confirming the financial results present true and fair view with no fraudulent transactions or significant changes in internal controls.
